Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01113099 · ClinicalTrials.gov registry record · NA

Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients

A NA study of Diabetes and Dyslipidemia, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
247
Enrollment target
1
Study location

NCT01113099 is a NA study of Diabetes and Dyslipidemia that has completed, run by Washington University School of Medicine. The registered enrollment target is 247 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01113099, a NA study of Diabetes and Dyslipidemia, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
247 participants
Enrollment target
1
Study location

Study Summary

We hypothesize that when compared to usual care a greater proportion of hospitalized diabetic patients who are candidates for cholesterol lowering will be discharged with a prescription for a statin if their physicians are contacted by a pharmacist to discuss treatment guidelines.

Conditions Studied

Interventions

  • OTHER Academic detailing

Study Locations (1)

Missouri

  • Barnes Jewish Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 247 participants
Start Date 2006-06
Est. Completion 2007-06
Phase NA

What the Registry Record Tells You About NCT01113099

The ClinicalTrials.gov registry entry for NCT01113099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Academic detailing is the first listed.

NCT01113099 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT01113099 about?

NCT01113099 is a clinical study titled "Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients". We hypothesize that when compared to usual care a greater proportion of hospitalized diabetic patients who are candidates for cholesterol lowering will be discharged with a prescription for a statin if their physicians are contacted by a pharmacist to discuss treatment guidelines.

What is the current status of trial NCT01113099?

This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2006-06. Estimated completion is 2007-06.

What conditions does trial NCT01113099 study?

This clinical trial studies the following conditions: Diabetes, Dyslipidemia.

What interventions are being tested in trial NCT01113099?

The interventions under investigation include: Academic detailing (OTHER).

Who is sponsoring clinical trial NCT01113099?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01113099 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.